INTRODUCTION: We investigated the value of lung perfusion imaging in predicting the risk of developing pulmonary complications after chemoradiation (CRT) or radiation therapy (RT) for lung cancer. METHODS: Fifty patients who underwent lung perfusion imaging before RT for lung cancer were included. Planar and single photon emission computed tomography/computed tomography images of the lungs were obtained. Lung perfusion score (LPS) was developed to visually grade localized perfusion defect per lung on a scale of 0 to 4 and perfusion pattern in the remaining lungs on a scale of 1 to 4. The LPS is the sum of the score for the localized perfusion defect in each lung plus the score for the remaining lungs perfusion. LPSs were correlated with pulmonary function tests and the patients were followed for 8 months after therapy to determine the incidence of grade 2 to 5 symptomatic therapy related pulmonary complications according to the common terminology criteria for adverse events (CTCAE 3.0). RESULTS: Thirty-four patients underwent CRT and 16 underwent RT. The mean total radiation dose delivered was 56.1 +/- 10.4 Gy. Eighteen patients (36%) suffered from pulmonary complications at a mean interval of 3.4 months after therapy. Nine patients had grade 2, 7 had grade 3, 1 had grade 4, and 1 had grade 5 pulmonary complications. The mean LPS was 4.9 in patients who developed pulmonary complications versus 3.5 in patients who did not (p = 0.01). There were no significant difference between pulmonary function tests in the patients with pulmonary complications and the patient without. In addition, there were no significant differences between the mean lung radiation dose, the volume of lung irradiated or the percentage of lung receiving greater than 20 Gy between the two groups. CONCLUSIONS: LPS using lung perfusion imaging is useful for predicting possible pulmonary complications after CRT or RT in lung cancer patients.
INTRODUCTION: We investigated the value of lung perfusion imaging in predicting the risk of developing pulmonary complications after chemoradiation (CRT) or radiation therapy (RT) for lung cancer. METHODS: Fifty patients who underwent lung perfusion imaging before RT for lung cancer were included. Planar and single photon emission computed tomography/computed tomography images of the lungs were obtained. Lung perfusion score (LPS) was developed to visually grade localized perfusion defect per lung on a scale of 0 to 4 and perfusion pattern in the remaining lungs on a scale of 1 to 4. The LPS is the sum of the score for the localized perfusion defect in each lung plus the score for the remaining lungs perfusion. LPSs were correlated with pulmonary function tests and the patients were followed for 8 months after therapy to determine the incidence of grade 2 to 5 symptomatic therapy related pulmonary complications according to the common terminology criteria for adverse events (CTCAE 3.0). RESULTS: Thirty-four patients underwent CRT and 16 underwent RT. The mean total radiation dose delivered was 56.1 +/- 10.4 Gy. Eighteen patients (36%) suffered from pulmonary complications at a mean interval of 3.4 months after therapy. Nine patients had grade 2, 7 had grade 3, 1 had grade 4, and 1 had grade 5 pulmonary complications. The mean LPS was 4.9 in patients who developed pulmonary complications versus 3.5 in patients who did not (p = 0.01). There were no significant difference between pulmonary function tests in the patients with pulmonary complications and the patient without. In addition, there were no significant differences between the mean lung radiation dose, the volume of lung irradiated or the percentage of lung receiving greater than 20 Gy between the two groups. CONCLUSIONS:LPS using lung perfusion imaging is useful for predicting possible pulmonary complications after CRT or RT in lung cancerpatients.
Authors: Christian J Müller; Martin Schwaiblmair; Juergen Scheidler; Michael Deimling; Juergen Weber; Ralf B Löffler; Maximilian F Reiser Journal: Radiology Date: 2002-02 Impact factor: 11.105
Authors: Katrien De Jaeger; Yvette Seppenwoolde; Liesbeth J Boersma; Sara H Muller; Paul Baas; José S A Belderbos; Joos V Lebesque Journal: Int J Radiat Oncol Biol Phys Date: 2003-04-01 Impact factor: 7.038
Authors: M P Sunyach; L Falchero; P Pommier; M Perol; D Arpin; M Vincent; D Boutry; P Rebatu; C Ginestet; I Martel-Lafay; D Perol; C Carrie Journal: Int J Radiat Oncol Biol Phys Date: 2000-09-01 Impact factor: 7.038
Authors: X L Fu; H Huang; G Bentel; R Clough; R L Jirtle; F M Kong; L B Marks; M S Anscher Journal: Int J Radiat Oncol Biol Phys Date: 2001-07-15 Impact factor: 7.038
Authors: L J Boersma; E M Damen; R W de Boer; S H Muller; R A Valdés Olmos; C A Hoefnagel; C M Roos; N van Zandwijk; J V Lebesque Journal: Radiother Oncol Date: 1993-11 Impact factor: 6.280
Authors: Tokihiro Yamamoto; Sven Kabus; Jens von Berg; Cristian Lorenz; Melody P Chung; Julian C Hong; Billy W Loo; Paul J Keall Journal: Acad Radiol Date: 2012-09-10 Impact factor: 3.173
Authors: Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Doug Arenberg; Xu-Wei Cai; Nithya Ramnath; Khaled Hassan; Jean Moran; Avraham Eisbruch; Randall K Ten Haken; Feng-Ming Spring Kong Journal: Int J Radiat Oncol Biol Phys Date: 2011-12-22 Impact factor: 7.038
Authors: Katherina P Farr; Stine Kramer; Azza A Khalil; Anni Morsing; Cai Grau Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-11 Impact factor: 9.236
Authors: Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Doug Arenberg; Jeffrey L Curtis; Xu-Wei Cai; Nithya Ramnath; Gregory P Kalemkerian; Randall K Ten Haken; Avraham Eisbruch; Feng-Ming Spring Kong Journal: J Thorac Oncol Date: 2011-01 Impact factor: 15.609
Authors: Rodolfo Núñez; William D Erwin; Richard E Wendt; Anne Stachowiak; Martha Mar; Donna Stevens; John E Madewell; Henry W Yeung; Homer A Macapinlac Journal: Mol Imaging Biol Date: 2010-01-05 Impact factor: 3.488
Authors: Hannah Mary T Thomas; Jing Zeng; Howard J Lee; Balu Krishna Sasidharan; Paul E Kinahan; Robert S Miyaoka; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen Journal: Br J Radiol Date: 2019-08-12 Impact factor: 3.039
Authors: Martha M Matuszak; Charles Matrosic; David Jarema; Daniel L McShan; Matthew H Stenmark; Dawn Owen; Shruti Jolly; Feng-Ming Spring Kong; Randall K Ten Haken Journal: Adv Radiat Oncol Date: 2016-10-29
Authors: Tokihiro Yamamoto; Michael S Kent; Erik R Wisner; Lynelle R Johnson; Joshua A Stern; Lihong Qi; Yukio Fujita; John M Boone Journal: Med Phys Date: 2016-07 Impact factor: 4.071